Regencell Bioscience Holdings Ltd (RGC) Market Cap & Valuation Ratios
Regencell Bioscience Holdings Ltd (RGC) has a market cap of $3.8B, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · read by EquiReason
RGCRegencell Bioscience Holdings LtdFollow RGC — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
drug manufacturers - specialty & generic · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| RGC | 3.8 | — | — | — | — | — | — | — |
| LNTH | 6.5 | 24.2 | 4.2 | 16.6 | 6.0% | +2% | 19% | 20% |
| AMRX | 6.5 | 41.6 | 2.9 | 14.0 | 1.3% | +9% | 15% | 17% |
| HIMS | 6.5 | — | 2.7 | — | 1.0% | +28% | -6% | -21% |
| KNSA | 6.0 | 78.3 | 6.5 | 53.5 | 3.1% | +59% | 12% | 18% |
| INDV | 4.1 | 12.4 | 3.3 | 10.1 | -2.7% | +13% | 32% | 667% |
| LQDA | 3.8 | 31.2 | 8.2 | 21.8 | 3.9% | +2234% | 37% | 180% |
| AMLX | 3.0 | — | — | — | -4.2% | — | — | -108% |
| SUPN | 2.4 | — | 2.6 | — | 0.8% | +25% | -16% | -15% |
| PBH | 2.3 | 13.4 | 3.8 | 13.0 | 10.4% | -1% | 26% | 6% |
| PRGO | 2.2 | — | 1.2 | — | 5.4% | -4% | -38% | -24% |
| Median of these 10 | 27.7 | 3.3 | 15.3 | 2.2% | +13% | 15% | 11% |
.
Growth vs. price
each dot a company · hover or tap for valuesRGC and HIMS and AMLX and SUPN and PRGO have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Regencell Bioscience Holdings Ltd — questions
- What is Regencell Bioscience Holdings Ltd's market cap?
- $3.8B.
Every figure on this page comes from Regencell Bioscience Holdings Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.